Intelligent Bio Solutions Inc (INBS)
2.27
-0.11
(-4.62%)
USD |
NASDAQ |
May 17, 16:00
2.22
-0.05
(-2.20%)
After-Hours: 20:00
Intelligent Bio Solutions Cash from Financing (Quarterly): 10.77M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.77M |
| December 31, 2023 | 3.786M |
| September 30, 2023 | |
| June 30, 2023 | 0.0461M |
| March 31, 2023 | 1.718M |
| December 31, 2022 | -0.3284M |
| September 30, 2022 | |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.4981M |
| December 31, 2020 | 19.61M |
| September 30, 2020 | 3.295M |
| June 30, 2020 | 0.2015M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.5323M |
| September 30, 2018 | 5.179M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.3284M
Minimum
Dec 2022
19.61M
Maximum
Dec 2020
2.508M
Average
0.1238M
Median
Cash from Financing (Quarterly) Benchmarks
| Ainos Inc | 0.7775M |
| OpGen Inc | 0.0275M |
| Zomedica Corp | -- |
| LENSAR Inc | -0.13M |
| Eargo Inc (DELISTED) | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.447M |
| Cash from Investing (Quarterly) | 0.0026M |
| Free Cash Flow | -7.266M |
| Free Cash Flow Per Share (Quarterly) | -1.175 |
| Free Cash Flow to Equity (Quarterly) | -2.361M |
| Free Cash Flow Yield | -525.5% |